Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters










Publication year range
1.
Radiat Oncol ; 11: 10, 2016 Jan 22.
Article in English | MEDLINE | ID: mdl-26800883

ABSTRACT

BACKGROUND: The aim of this study is to evaluate the radiobiological impact of Acuros XB (AXB) vs. Anisotropic Analytic Algorithm (AAA) dose calculation algorithms in combined dose-volume and biological optimized IMRT plans of SBRT treatments for non-small-cell lung cancer (NSCLC) patients. METHODS: Twenty eight patients with NSCLC previously treated SBRT were re-planned using Varian Eclipse (V11) with combined dose-volume and biological optimization IMRT sliding window technique. The total dose prescribed to the PTV was 60 Gy with 12 Gy per fraction. The plans were initially optimized using AAA algorithm, and then were recomputed using AXB using the same MUs and MLC files to compare with the dose distribution of the original plans and assess the radiobiological as well as dosimetric impact of the two different dose algorithms. The Poisson Linear-Quadatric (PLQ) and Lyman-Kutcher-Burman (LKB) models were used for estimating the tumor control probability (TCP) and normal tissue complication probability (NTCP), respectively. The influence of the model parameter uncertainties on the TCP differences and the NTCP differences between AAA and AXB plans were studied by applying different sets of published model parameters. Patients were grouped into peripheral and centrally-located tumors to evaluate the impact of tumor location. RESULTS: PTV dose was lower in the re-calculated AXB plans, as compared to AAA plans. The median differences of PTV(D95%) were 1.7 Gy (range: 0.3, 6.5 Gy) and 1.0 Gy (range: 0.6, 4.4 Gy) for peripheral tumors and centrally-located tumors, respectively. The median differences of PTV(mean) were 0.4 Gy (range: 0.0, 1.9 Gy) and 0.9 Gy (range: 0.0, 4.3 Gy) for peripheral tumors and centrally-located tumors, respectively. TCP was also found lower in AXB-recalculated plans compared with the AAA plans. The median (range) of the TCP differences for 30 month local control were 1.6 % (0.3 %, 5.8 %) for peripheral tumors and 1.3 % (0.5 %, 3.4 %) for centrally located tumors. The lower TCP is associated with the lower PTV coverage in AXB-recalculated plans. No obvious trend was observed between the calculation-resulted TCP differences and tumor size or location. AAA and AXB yield very similar NTCP on lung pneumonitis according to the LKB model estimation in the present study. CONCLUSION: AAA apparently overestimates the PTV dose; the magnitude of resulting difference in calculated TCP was up to 5.8 % in our study. AAA and AXB yield very similar NTCP on lung pneumonitis based on the LKB model parameter sets we used in the present study.


Subject(s)
Carcinoma, Non-Small-Cell Lung/radiotherapy , Lung Neoplasms/radiotherapy , Radiosurgery/methods , Radiotherapy, Intensity-Modulated/methods , Tomography, X-Ray Computed , Aged , Aged, 80 and over , Algorithms , Dose Fractionation, Radiation , Female , Humans , Linear Models , Male , Middle Aged , Poisson Distribution , Probability , Radiation Pneumonitis/physiopathology , Radiometry , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted
2.
Technol Cancer Res Treat ; 15(1): 91-100, 2016 Feb.
Article in English | MEDLINE | ID: mdl-24000988

ABSTRACT

Spatially fractionated radiation therapy (GRID) with megavoltage x-ray beam is typically used to treat large and bulky malignant tumors. Currently most of the GRID treatment is performed by using the linear accelerator with either the multileaf collimator or with the commercially available block. A novel method to perform GRID treatments using Helical Tomotherapy (HT) was developed at the Radiation Oncology Department, College of Medicine, the University of Arkansas for Medical Sciences. In this study, we performed a dosimetric comparison of two techniques of GRID therapy: one on linear accelerator with a commercially available GRID block (LINAC-GRID) as planned on the Pinnacle planning station (P-TPS); and helical tomotherapy-based GRID (HT-GRID) technique using a novel virtual TOMOGRID template planned on Tomotherapy treatment planning station (HT-TPS). Three dosimetric parameters: gross target volume (GTV) dose distribution, GTV target dose inhomogeneity, and doses to regions of interest were compared. The comparison results show that HT-GRID dose distributions are comparable to those of LINAC-GRID for GTV coverage. Doses to the majority of organs-at-risk (OAR) are lower in HT-GRID as compared to LINAC-GRID. The maximum dose to the normal tissue is reduced by 120% for HT-GRID as compared to the LINACGRID. This study indicate that HT-GRID can be used to deliver spatially fractionated dose distributions while allowing 3-D optimization of dose to achieve superior sparing of OARs and confinement of high dose to target.


Subject(s)
Neoplasms/radiotherapy , Radiotherapy Planning, Computer-Assisted , Dose Fractionation, Radiation , Humans , Neoplasms/diagnostic imaging , Particle Accelerators , Phantoms, Imaging , Radiotherapy, Intensity-Modulated , Tomography, Spiral Computed , User-Computer Interface
3.
Technol Cancer Res Treat ; 14(4): 440-6, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25398680

ABSTRACT

The objective of this study is to compare the new and conventional tomotherapy treatment techniques and to evaluate dosimetric differences between them. A dosimetric analysis was performed by comparing planning target volume (PTV) median dose, 95% of PTV dose coverage, Paddick conformity index (CI), homogeneity index (HI), whole-body integral dose, and OAR median doses. The beam on time (BOT) and the effect of different jaw sizes and pitch values was studied. The study results indicated that the PTV dose coverage for all the techniques was comparable. Treatment plans using dynamic jaw reduced OAR doses to structures located at the treatment field edge compared to fixed jaw plans. The HT-3DCRT plans resulted in higher OAR doses to kidney, liver, and lung compared to the other techniques, and TD-IMRT provided the best dose sparing to liver compared to other techniques. Whole-body integral dose differences were found to be insignificant among the techniques. BOT was found to be higher for fixed jaw treatment plan compared to dynamic jaw plan and comparable between all treatment techniques with 5-cm dynamic jaw. In studying effect of jaw size, better OAR sparing and HI were found for 2.5-cm jaw but at the expense of doubling of BOT as compared to 5-cm jaw. There was no significant improvement found in OAR sparing when the pitch value was increased. Increasing the pitch from 0.2 to 0.43, the CI was improved, HI improved only for 5-cm jaw size, and BOT decreased to approximately half of its original time.


Subject(s)
Craniospinal Irradiation , Radiometry , Radiotherapy , Craniospinal Irradiation/methods , Humans , Neoplasms/radiotherapy , Organ Sparing Treatments , Radiometry/methods , Radiotherapy/methods , Radiotherapy Planning, Computer-Assisted , Radiotherapy, Intensity-Modulated/methods
4.
Br J Cancer ; 106(5): 916-22, 2012 Feb 28.
Article in English | MEDLINE | ID: mdl-22333602

ABSTRACT

BACKGROUND: In early-stage breast cancer, adjuvant chemotherapy is associated with significant systemic toxicity with only a modest survival benefit. Therefore, there is considerable interest in identifying predictive markers of response to therapy. Doxorubicin, one of the most common drugs used to treat breast cancer, is an anthracycline chemotherapeutic agent, a class of drugs known to be affected by hypoxia. Accordingly, we examined whether expression of the endogenous hypoxia marker carbonic anhydrase IX (CA IX) is predictive of outcome in early-stage breast cancer patients treated with doxorubicin. METHODS: We obtained 209 early-stage pre-treatment surgically-resected breast tumours from patients, who received doxorubicin in their chemotherapeutic regimen and had >10 years of follow-up. Immunohistochemistry was used to detect CA IX, and we used fluorescence in situ hybridisation to detect both human epidermal growth factor receptor (HER2) and DNA topoisomerase II-alpha (TOP2A) gene amplification. RESULTS: Carbonic anhydrase IX intensity was significantly correlated with progression-free survival (PFS) and overall survival (OS) in patients receiving 300 mg m(-2) of doxorubicin (HR=1.82 and 3.77; P=0.0014 and 0.010, respectively). There was a significant, inverse correlation between CA IX score and oestrogen receptor expression, but no significant correlations were seen with either HER2 or TOP2A ratio. CONCLUSION: We demonstrate that CA IX expression is correlated with worse PFS and OS for breast cancer patients treated with doxorubicin, independent of HER2 or TOP2A gene amplification. This study provides evidence that using CA IX to detect hypoxia in surgically-resected breast tumours may be of clinical use in choosing an appropriate chemotherapy regimen.


Subject(s)
Antibiotics, Antineoplastic/therapeutic use , Antigens, Neoplasm/metabolism , Breast Neoplasms/drug therapy , Carbonic Anhydrases/metabolism , Doxorubicin/therapeutic use , Drug Resistance, Neoplasm , Adult , Aged , Antigens, Neoplasm/genetics , Biomarkers, Tumor , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Carbonic Anhydrase IX , Cell Hypoxia , Chemotherapy, Adjuvant , DNA Topoisomerases, Type II/genetics , DNA-Binding Proteins/genetics , Disease-Free Survival , Female , Gene Amplification , Genes, erbB-2 , Humans , Middle Aged , Poly-ADP-Ribose Binding Proteins
5.
Br J Cancer ; 93(12): 1350-5, 2005 Dec 12.
Article in English | MEDLINE | ID: mdl-16288305

ABSTRACT

Tumour hypoxia has been shown to increase mutation rate, angiogenesis, and metastatic potential, and decrease response to conventional therapeutics. Improved tumour oxygenation should translate into increased treatment response. Exogenous recombinant erythropoietin (rEpo) has been recently shown to increase tumour oxygenation in a mammary carcinoma model. The mechanism of this action is not yet understood completely. The presence of Epo and its receptor (EpoR) have been demonstrated on several normal and neoplastic tissues, including blood vessels and various solid tumours. In addition, rEpo has been shown in two recent prospective, randomized clinical trials to negatively impact treatment outcome. In this study, we attempt to characterize the direct effects of rEpo on tumour growth and angiogenesis in two separate rodent carcinomas. The effect of rEpo on R3230 rat mammary adenocarcinomas, CT-26 mouse colon carcinomas, HCT-116 human colon carcinomas, and FaDu human head and neck tumours, all of which express EpoR, was examined. There were no differences in tumour growth or proliferation (measured by Ki-67) between placebo-treated and rEpo-treated tumours. In the mammary window chamber, vascular length density (VLD) measurements in serial images of both placebo-treated and Epo-treated rats revealed no difference in angiogenesis between the Epo-treated tumours and placebo-treated tumours at any time point. These experiments are important because they suggest that the recent clinical detriment seen with the use of Epo is not due to its tumour growth effects or angiogenesis. These studies also suggest that further preclinical studies need to examine rEpo's direct tumour effects in efforts to improve the therapeutic benefits of Epo in solid tumour patients.


Subject(s)
Carcinoma/pathology , Cell Proliferation/drug effects , Colonic Neoplasms/pathology , Erythropoietin/pharmacology , Head and Neck Neoplasms/pathology , Mammary Neoplasms, Animal/pathology , Neovascularization, Pathologic , Animals , Cell Hypoxia , Humans , Mice , Placebos , Random Allocation , Rats , Recombinant Proteins , Tumor Cells, Cultured
6.
Psychooncology ; 8(2): 167-76, 1999.
Article in English | MEDLINE | ID: mdl-10335560

ABSTRACT

BACKGROUND: Over the past decade, high dose chemotherapy with autologous bone marrow (HDC-ABMT) support has been used increasingly in the treatment of patients with breast cancer. In evaluating the results of HDC-ABMT in patients with breast cancer, an assessment of quality of life can add to the traditional endpoints (toxicity, and disease-free and overall survival) that are routinely assessed in clinical trials. PURPOSE: This study evaluated the quality of life (QOL) of breast cancer patients who had survived 1 or more years following high dose chemotherapy with autologous bone marrow transplant (HDC-ABMT) support. METHODS: Eighty-two patients who had undergone HDC-ABMT were surveyed by written questionnaire and follow-up telephone interview at least 1 year following HDC-ABMT. Patients were asked to complete the Functional Living Index-Cancer (FLIC), the Symptom Distress Scale (SDS), and a survey of sexual function developed as part of the study. RESULTS: The mean FLIC score among all patients was 130 +/- 19.1 (possible range 22-154). FLIC scores were significantly lower in patients with evidence of recurrent disease than in patients who were free of disease. The most commonly reported symptoms after HDC-ABMT were insomnia, fatigue, and pain. Sexual interest and sexual activity were reported to be lower after participation in HDC-ABMT than prior to the procedure. The majority of patients who were employed outside the home prior to HDC-ABMT returned to work with a median time away from work of 48 weeks. CONCLUSIONS: Patients with breast cancer who survive 1 or more years following HDC-ABMT rate their QOL at a relatively high level and frequently return to work. Less than one-third of patients who were interviewed reported moderate to severe symptoms. Problems with sexual functioning were common. IMPLICATIONS: Future research is needed on long-term outcomes after HDC-ABMT and on specific areas of concern, such as sexual functioning.


Subject(s)
Bone Marrow Transplantation/psychology , Breast Neoplasms/therapy , Drug Therapy/psychology , Quality of Life , Survival , Transplantation, Autologous , Adult , Combined Modality Therapy , Depressive Disorder/diagnosis , Depressive Disorder/psychology , Dose-Response Relationship, Drug , Female , Humans , Middle Aged , Sexual Behavior/psychology , Surveys and Questionnaires , Time Factors
8.
J Leukoc Biol ; 60(1): 27-36, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8699120

ABSTRACT

Subcutaneous injection of recombinant human interleukin-2 (rhuIL-2) at 10(2)-10(4) U/mouse induced delayed (48 h) accumulation of mononuclear leukocytes with diffuse granulocytes, including eosinophils. Subcutaneous local infusion of rhuIL-2 or recombinant murine IL-2 (10(2)-10(4) U/mouse) via implanted Alzet miniosmotic pumps in mice induced chronic inflammatory lesions characterized by infiltration of large vacuolated mononuclear leukocytes, lymphoid cells, and eosinophil foci; neovascularization, with high endothelial-like cells, was prominent, exhibiting intravascular trapping and migration of large mononuclear leukocytes. Leukocyte infiltrates comprised T lymphocytes (CD4+; CD8+), B lymphocytes, and macrophages. Control infusions of bovine serum albumin (BSA) induced weak fibrotic lesions with sparse macrophage infiltration and minimal accumulation of lymphocytes; VLA4+ and ICAM-1+ leukocyte infiltrates were significantly greater in IL-2-induced lesions compared with BSA-induced lesions. Quantitative image analysis showed significantly increased lesion size in the IL-2-induced lesions compared with those induced by BSA infusion. The vascularity of IL-2-induced lesions assessed by immunostaining for platelet-endothelial cell adhesion molecule was increased compared with control, BSA-induced lesions mainly due to neovascularization. ICAM-1 and VCAM-1 expression was significantly enhanced in IL-2 lesions. No systemic pathological changes were observed following IL-2 infusion. We conclude that local slow-release of IL-2 causes the evolution and maintenance of a specific chronic inflammatory lesion.


Subject(s)
Cell Adhesion Molecules/biosynthesis , Granulomatous Disease, Chronic/physiopathology , Inflammation , Interleukin-2/toxicity , Animals , Antigens, Differentiation, Myelomonocytic/analysis , Antigens, Differentiation, Myelomonocytic/biosynthesis , Cattle , Cell Adhesion Molecules/analysis , Eosinophils/drug effects , Eosinophils/pathology , Eosinophils/physiology , Female , Granulocytes/drug effects , Granulocytes/pathology , Granulocytes/physiology , Granulomatous Disease, Chronic/chemically induced , Granulomatous Disease, Chronic/pathology , Humans , Intercellular Adhesion Molecule-1/analysis , Intercellular Adhesion Molecule-1/biosynthesis , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/pathology , Leukocytes, Mononuclear/physiology , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Platelet Endothelial Cell Adhesion Molecule-1 , Recombinant Proteins/toxicity , Reference Values , Serum Albumin, Bovine , Vascular Cell Adhesion Molecule-1/analysis , Vascular Cell Adhesion Molecule-1/biosynthesis
9.
J Endod ; 20(8): 377-80, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7996103

ABSTRACT

Fifty canals of extracted single-rooted teeth were prepared to a size 50 master apical file, sterilized in ethylene oxide, and inoculated with a known quantity of Bacillus stearothermophilus spores. Five groups of 10 canals each were used. The control group received no treatment. The four treatment groups were exposed to pulsed Nd:YAG laser radiation or 0.5% NaOCl alone and in combination. The root canals were flushed with sterile distilled water to recover spores, and serial dilutions were incubated on blood agar and the number of colony-forming units recovered was determined. Analysis of the data indicated a 2-log reduction in colony-forming units among the four treatment groups as compared with the controls; however, no significant differences were observed among the treatment groups. In none of the treatment groups were the root canals sterilized.


Subject(s)
Dental Pulp Cavity/microbiology , Geobacillus stearothermophilus/radiation effects , Lasers , Colony Count, Microbial , Humans , Neodymium , Root Canal Therapy/methods , Sodium Hypochlorite
10.
Pharmacol Biochem Behav ; 42(3): 509-15, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1409782

ABSTRACT

The effects of cocaine exposure in utero on cocaine-induced behaviors and dopamine (DA) transmission in the nigrostriatal and mesolimbic pathways were measured in adult rats. Pregnant rats received either saline or cocaine (1 or 3 mg/kg, IV) daily throughout gestation. When offspring were 3 months of age, locomotor and stereotypic behaviors were rated after an injection of either saline or cocaine (10 mg/kg, IP). Cocaine in utero increased the response to cocaine in adult offspring and increased basal locomotion in female offspring. Cocaine in utero increased amphetamine-stimulated release in female offspring but decreased release in males. On the other hand, male rats that had received cocaine in utero exhibited greater basal tritium release. One injection of cocaine increased amphetamine-stimulated [3H]DA release from striatal slices of male rats but not female rats. Neither cocaine in utero nor in vivo affected D2 DA receptor binding in striatum nor nucleus accumbens. Thus, cocaine in utero behaviorally sensitized animals to subsequent cocaine exposure and increased [3H]DA release from nigrostriatal endings, but the relationship of these two variables depended upon gender.


Subject(s)
Cocaine/pharmacology , Prenatal Exposure Delayed Effects , Animals , Body Weight/drug effects , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Female , Male , Motor Activity/drug effects , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Pregnancy , Rats , Rats, Sprague-Dawley , Receptors, Dopamine/drug effects , Receptors, Dopamine/metabolism , Spiperone/metabolism , Stereotyped Behavior/drug effects
11.
Alcohol Clin Exp Res ; 16(2): 311-9, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1317135

ABSTRACT

One of ethanol's actions after acute exposure is anticonvulsant activity whereas withdrawal from chronic ethanol exposure increases convulsant activity. An increase in neuronal transmission in the GABAergic pathways from striatum to the substantia nigra (SN) and a decrease in GABAergic transmission from SN to superior colliculus (SC) both appear to play a major role in inhibiting seizure propagation. If this is the case, then the changes in seizure sensitivity caused by ethanol may be expected to affect GABAergic transmission in opposite ways in SN and SC. We measured the effects of in vitro ethanol on pre- and postsynaptic indices of GABA transmission using SN and SC tissue from both ethanol-naive rats and rats given ethanol in their drinking water for 24 days and then withdrawn for 24 hr, a treatment that decreases seizure latency. While ethanol inhibited 3H-GABA release from slices of SC at low concentrations (20-100 nM), much higher concentrations were required to inhibit release from SN (100-500 mM). In fact, release from SN was increased by low concentrations of ethanol. Ethanol in vitro (20-1000 mM) also inhibited specific binding of 35S-TBPS to the GABAA receptor but this effect was similar in both potency and efficacy in SC and SN. Next, the in vitro effects of ethanol were measured in rats that had consumed an average of 9.8 g ethanol/kg body weight/day and were then withdrawn for 24 hr. Ethanol inhibition of 3H-GABA release from SC was significantly less in ethanol-treated rats compared to controls whereas the inhibitory effect of ethanol was increased in SN from ethanol-treated rats.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Alcohol Withdrawal Delirium/physiopathology , Alcoholism/physiopathology , Ethanol/toxicity , Substantia Nigra/drug effects , Superior Colliculi/drug effects , Synaptic Transmission/drug effects , gamma-Aminobutyric Acid/physiology , Animals , Autoradiography , Brain Mapping , Culture Techniques , Male , Neural Pathways/drug effects , Neural Pathways/physiopathology , Neurons/drug effects , Neurons/physiology , Rats , Rats, Inbred Strains , Receptors, GABA-A/drug effects , Receptors, GABA-A/physiology , Seizures/physiopathology , Substantia Nigra/physiopathology , Superior Colliculi/physiopathology , Synaptic Transmission/physiology
12.
Brain Res ; 566(1-2): 255-64, 1991 Dec 06.
Article in English | MEDLINE | ID: mdl-1814541

ABSTRACT

Locomotor activity and stereotypy induced by cocaine is increased or 'sensitized' after repeated cocaine administration. This behavioral sensitization may be mediated by a persistent increase in dopamine (DA) transmission in mesolimbic and nigrostriatal pathways. Since the female estrous cycle and ovarian steroid hormones appear to affect both cocaine sensitization and DA transmission, studies were undertaken to determine the effects of ovarian steroids on sensitization of the behavioral responses to repeated cocaine injections and any concomitant effects on striatal DA release. Young female adult rats were ovariectomized and 2 weeks later were implanted with chronic release forms of estradiol (E), progesterone (P), both (EP) or vehicle (V). Locomotor and stereotypic behavior were rated after an initial injection of either saline or cocaine (10 mg/kg, i.p.) and after the 8th daily injection of saline or cocaine. A significant increase in both locomotor and stereotypic behaviors was seen after the first cocaine injection relative to saline-injected animals and this response was not affected by steroid treatment. Repeated injections of cocaine caused sensitization of the initial behavioral response to cocaine (i.e. an increase in stereotypic and locomotor behavior) and the degree of cocaine sensitization was greatest in group E. Steroid treatment did not affect behavior in saline-treated rats. When striatal [3H]DA release was measured in vitro 1 or 7 days after the last injection, amphetamine-stimulated release was greater in vehicle-treated rats 7 days after cocaine injections but not 1 day after injections. In contrast, release was enhanced in group E both 1 and 7 days after cocaine.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Amphetamine/pharmacology , Cocaine/pharmacology , Corpus Striatum/metabolism , Dopamine/metabolism , Estradiol/pharmacology , Motor Activity/drug effects , Progesterone/pharmacology , Stereotyped Behavior/drug effects , Animals , Body Weight/drug effects , Corpus Striatum/drug effects , Drug Synergism , Estradiol/blood , Female , Male , Organ Size/drug effects , Pituitary Gland/drug effects , Progesterone/blood , Rats , Rats, Inbred Strains , Reference Values , Substance Withdrawal Syndrome/physiopathology , Uterus/drug effects
13.
Res Vet Sci ; 50(1): 54-63, 1991 Jan.
Article in English | MEDLINE | ID: mdl-2047592

ABSTRACT

Horses with colic may be endotoxaemic and subsequently develop hypotension during anaesthesia for surgical operation. The aim of this study was to evaluate the efficacy of dopamine as a means to improve cardiovascular function in anaesthetised endotoxaemic horses. Nine horses (five in group 1 and four in group 2) were anaesthetised with thiopentone and guaifenesin and anaesthesia was maintained with halothane. After approximately one hour, facial artery pressure, heart rate, pulmonary artery pressure, cardiac output, temperature, pHa, PaCO2, PaO2, base excess, packed cell volume, plasma protein concentration and white cell count were measured (time 0). Escherichia coli endotoxin was infused intravenously over 15 minutes in both groups. Group 2 horses were given an intravenous infusion of dopamine (5 micrograms kg-1 min-1) starting five minutes after the start of the endotoxin infusion and continuing for 60 minutes. Measurements were made at 15 minute intervals for 120 minutes. In group 1, one horse died during the endotoxin infusion and in two other horses mean facial artery pressures decreased to 50 mm Hg. Total pulmonary vascular resistance and packed cell volume were significantly increased. Cardiac output, cardiac index and change in mean arterial pressure were significantly greater in group 2 horses than in group 1 horses. Conversely, diastolic pulmonary artery pressure, total vascular resistance and total pulmonary resistance were significantly less in group 2 than in group 1. PaO2, base excess and white blood cell count were significantly decreased in both groups. It was concluded that dopamine improved cardiovascular function in the presence of endotoxaemia and attenuated the rate of haemoconcentration, but had no effect on the development of decreased PaO2 or metabolic acidosis.


Subject(s)
Dopamine/pharmacology , Endotoxins/toxicity , Escherichia coli , Hemodynamics/drug effects , Horse Diseases/physiopathology , Toxemia/veterinary , Acid-Base Equilibrium/drug effects , Anesthesia/veterinary , Animals , Blood Glucose/analysis , Female , Halothane , Hematocrit/veterinary , Horses , Hydrogen-Ion Concentration , Lactates/blood , Leukocyte Count/veterinary , Male , Oxygen/blood , Toxemia/physiopathology
14.
Hora vet ; 10(56): 6-8, jul.-ago. 1990. ilus
Article in Portuguese | LILACS | ID: lil-94641

ABSTRACT

A aplicaçäo de Flunixin Meglumine antes do desafio endotoxínico causou significante supressäo na geraçäo plasmática de tramboxane e 6-Keto-prostaglandina F1 alfa em eqüinos. Na dose de 0,25 mg/kg de peso vivo, o produto provocou, em cavalos pré-medicados, significativa supressäo nos índices elevados de lactado sangüíneo. A reduçäo dos sintomas clínicos de endotoxemia por açäo do Flunixin Meglumine foi dependente, facilitando a avaliaçäo clínica do animal


Subject(s)
Animals , Analgesics , Endotoxins , Horses
15.
Alcohol ; 6(4): 297-301, 1989.
Article in English | MEDLINE | ID: mdl-2765198

ABSTRACT

The effect of the anticonvulsive drug carbamazepine on ethanol-induced motor incoordination and loss-of-righting reflex was investigated in male CD-1 mice. The results of the investigation showed that carbamazepine significantly potentiated the motor incoordinating effect of ethanol in a dose-dependent fashion. Although carbamazepine did not alter the onset time, it significantly prolonged the duration of ethanol-induced loss-of-righting reflex. Pretreatment with theophylline significantly attenuated the carbamazepine-induced potentiation of ethanol-induced motor incoordination and loss-of-righting reflex. Results from a blood ethanol study indicated no effect of carbamazepine on the clearance of ethanol. The data suggest the involvement of nonadenosinergic mechanism in carbamazepine-ethanol behavioral interactions which is responsible for the accentuating effects of carbamazepine on ethanol-induced motor incoordination and duration of loss-of-righting reflex.


Subject(s)
Adenosine/physiology , Behavior, Animal/drug effects , Brain Chemistry/drug effects , Carbamazepine/pharmacology , Ethanol/pharmacology , Animals , Drug Interactions , Ethanol/blood , Male , Mice , Motor Activity/drug effects , Purinergic Antagonists , Reflex/drug effects
16.
Agents Actions ; 27(3-4): 290-3, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2508441

ABSTRACT

The contention that cytokines are important mediators of inflammation prompted the present studies which were designed to compare acute and chronic pathological effects of locally-administered recombinant (r) IL-1 alpha, IL-1 beta, TNF alpha, IL-2 and Ifn gamma. Acute (6 hr), resolving (48 hr) inflammation was induced by the following, in order of potency: rIL-1 alpha greater than rIL-1 beta greater than rTNF alpha greater than rIfn gamma = BSA (control) following a single sc. injection. However, only rIL-1 beta and rIL-2 initiated and maintained chronic granulomatous reactions when delivered locally from a sc. ethylene vinyl acetate (EVA) slow-release polymer. The predominance of macrophages in EVA-rIL-1 beta lesions contrasted with the proliferative lymphoid granulomata induced by EVA-rIL-2 implants. These "in vivo" observations reinforce the roles of both IL-1 beta and IL-2 as potent mediators of chronic immunoinflammatory disease.


Subject(s)
Inflammation/chemically induced , Interferon-gamma/toxicity , Interleukin-1/toxicity , Interleukin-2/toxicity , Tumor Necrosis Factor-alpha/toxicity , Animals , Female , Inflammation/pathology , Injections, Subcutaneous , Mice , Recombinant Proteins/toxicity , Skin/pathology
17.
Clin Sci (Lond) ; 76(3): 261-3, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2494015

ABSTRACT

1. The present study describes the pathological responses to local administration of recombinant cytokines in subcutaneously implanted slow-release ethylene vinyl acetate (EVA) co-polymer in mice. 2. EVA-recombinant human interleukin-1 beta (10(4) units) implants induced the formation of chronic granulomatous inflammatory tissue between 4 and 7 days after implantation, characterized by predominant macrophage infiltration, neovascularization and fibrosis which persisted up to 21 days after-implantation. EVA-recombinant human interleukin-1 alpha (10(4)-10(5) units) implants induced a qualitatively similar but less intense response. 3. In contrast, recombinant human interleukin-2 (10(2)-10(4) units) implants resulted in early lymphocytic vasculitis (4 days) and the development of a predominantly lymphoid lesion comprised of lymphoblasts and significant mononuclear cell proliferation by 7 days. 4. EVA-recombinant gamma-interferon (10(3)-10(4) units) implants failed to elicit a significant tissue response; with the exception of multinucleate giant cell formation the characteristics of these lesions closely resembled the mild fibrotic responses observed for EVA-bovine serum albumin (0.5-12.5 mg) implants. 5. These observations suggest that continuous endogenous local release of interleukin-1 or interleukin-2 in vivo is sufficient for the development of specific pathological features characterizing chronic immuno-inflammatory diseases.


Subject(s)
Inflammation/etiology , Interferon-gamma/pharmacology , Interleukin-1/pharmacology , Interleukin-2/pharmacology , Animals , Chronic Disease , Delayed-Action Preparations , Female , Inflammation/pathology , Interferon-gamma/administration & dosage , Interleukin-1/administration & dosage , Interleukin-2/administration & dosage , Mice , Mice, Inbred Strains , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacology
19.
Immunopharmacology ; 15(1): 47-62, 1988.
Article in English | MEDLINE | ID: mdl-3258857

ABSTRACT

The effects of a panel of hormones and pharmacological agents on the activation of T cells by a combination of interleukin-1 and phytohemagglutinin (IL-1/PHA) was studied. Pharmacological effects on various stages of IL-1/PHA-induced interleukin-2 (IL-2) production by the cloned murine thymoma cell line LBRM-33-1A5.7 were dissected using a multi-step assay procedure. A 4-h lag phase in the kinetics of IL-2 production allowed the operational definition of an early, IL-1-dependent programming stage, followed by an IL-2-production stage of the assay. A cell-washing procedure between these stages was introduced in order to distinguish IL-1 receptor antagonists from functional IL-1/PHA antagonists. Hydrocortisone and cyclosporine were potent inhibitors (active in the nM range) of both stages of IL-2 production, suggesting that neither is an IL-1 receptor antagonist. The cyclic adenosine monophosphate (cAMP)-elevating agents prostaglandin E2, dibutyryl cAMP, and theophylline inhibited IL-2 production during the early, IL-1-dependent programming stage. By contrast, prostaglandin F2 alpha and dibutyryl cyclic guanosine monophosphate did not appreciably inhibit IL-1/PHA activity. These results are discussed in relationship to the effects of these test agents in thymocyte IL-1 assays or mitogenesis assays and the implications toward understanding the mechanisms underlying IL-1/PHA activation of T cells.


Subject(s)
Interleukin-1/pharmacology , Lymphocyte Activation/drug effects , T-Lymphocytes/drug effects , Animals , Cell Line , Cyclosporins/pharmacology , Hydrocortisone/pharmacology , Interleukin-2/biosynthesis , Mice , Nucleotides, Cyclic/pharmacology , Phytohemagglutinins/pharmacology , Prostaglandins/pharmacology , T-Lymphocytes/immunology
20.
Equine Vet J ; 19(3): 201-6, 1987 May.
Article in English | MEDLINE | ID: mdl-3608957

ABSTRACT

The efficacy of low doses of flunixin meglumine in reducing eicosanoid generation and clinical signs in response to experimentally induced endotoxaemia was investigated. Thromboxane B2 and 6-keto-prostaglandin F1 alpha were measured in serum and plasma by radioimmunoassay. Plasma flunixin concentrations were determined by high performance liquid chromatography and pharmacokinetic parameters derived non-compartmentally. In horses administered flunixin meglumine before endotoxin challenge, a significant suppression in plasma thromboxane B2 and 6-keto-prostaglandin F1 alpha generation was observed. Elevations in blood lactate were significantly suppressed in horses pretreated with 0.25 mg/kg bodyweight flunixin meglumine. Reduction of the clinical signs of endotoxaemia by flunixin meglumine was dose dependent. Low doses of flunixin inhibited eicosanoid production without masking all of the physical manifestations of endotoxaemia necessary for accurate clinical evaluation of the horse's status.


Subject(s)
6-Ketoprostaglandin F1 alpha/blood , Clonixin/pharmacology , Horse Diseases/metabolism , Nicotinic Acids/pharmacology , Thromboxane B2/blood , Toxemia/veterinary , Animals , Clonixin/analogs & derivatives , Clonixin/metabolism , Clonixin/therapeutic use , Endotoxins , Horse Diseases/drug therapy , Horses , Kinetics , Lactates/blood , Random Allocation , Toxemia/drug therapy , Toxemia/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...